ASCO Roundup: Looking For The Future Of Cancer Research

As the American Society of Clinical Oncology annual meeting drew to a close, Scrip spoke with industry execs about staying competitive, adjusting to policy changes and how artificial intelligence is advancing cancer R&D.

In addition to covering some of the biggest datasets released at the ASCO meeting, Scrip interviewed a range of biopharma industry executives about what it takes to stay competitive in the most active area of drug development.

For oncology leaders, that means matching unmet need with transformational opportunities, balancing multiple modalities and staying nimble – as well...